Literature DB >> 6700592

Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome.

D Hanahan, Y Gluzman.   

Abstract

A variant of the adenovirus type 5 genome which lacks EcoRI sites has been cloned in a bacterial plasmid after the addition of EcoRI oligonucleotide linkers to its ends. Closed circular forms of the recombinant viral genome were not infectious upon their introduction into permissive eucaryotic cells. The linear genome released by digestion of the 39-kilobase recombinant plasmid (pXAd) with EcoRI produced infectious virus at about 5% of the level of wild-type controls. The viruses which arose were indistinguishable from the parental strain, and the normal termini of the viral genome had been restored. Marker rescue experiments demonstrate that provision of a DNA fragment with a normal viral end improves infectivity. When a small fragment carrying a wild-type left end (the 0 to 2.6% ClaI-B fragment) was ligated to ClaI-linearized pXAd, virus was produced with efficiencies comparable to a similar reconstitution of the two ClaI fragments of the wild-type genome. These viruses stably carry the left-end fragment at both ends, leaving the normal right end embedded in 950 base pairs of DNA. The embedded right origin is inactive. The consensus of the analyses reported here is that a free end is a necessary configuration for the sequences which make up the adenovirus origin of replication.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6700592      PMCID: PMC368696          DOI: 10.1128/mcb.4.2.302-309.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  Sequence specificity of the P1 modification methylase (M.Eco P1) and the DNA methylase (M.Eco dam) controlled by the Escherichia coli dam gene.

Authors:  S Hattman; J E Brooks; M Masurekar
Journal:  J Mol Biol       Date:  1978-12-15       Impact factor: 5.469

3.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2.

Authors:  U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1973-01       Impact factor: 5.469

4.  Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV.

Authors:  R J Samulski; A Srivastava; K I Berns; N Muzyczka
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

5.  Evidence for blocked 5'-termini in human adenovirus DNA.

Authors:  E A Carusi
Journal:  Virology       Date:  1977-01       Impact factor: 3.616

6.  Genetic and physical linkage of exogenous sequences in transformed cells.

Authors:  M Perucho; D Hanahan; M Wigler
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

7.  Isolation of deletion and substitution mutants of adenovirus type 5.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

8.  Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome.

Authors:  M L Hammarskjöld; G Winberg
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

9.  The nucleotide sequence of the transforming HpaI-E fragment of adenovirus type 5 DNA.

Authors:  H Van Ormondt; J Maat; A De Waard; A J Van der Eb
Journal:  Gene       Date:  1978-12       Impact factor: 3.688

10.  The nucleotide sequence of the right-hand terminus of adenovirus type 5 DNA: implications for the mechanism of DNA replication.

Authors:  P H Steenbergh; J S Sussenbach
Journal:  Gene       Date:  1979-08       Impact factor: 3.688

View more
  14 in total

1.  Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.

Authors:  X Wang; W Zeng; M Murakawa; M W Freeman; B Seed
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Human adenovirus type 9-induced rat mammary tumors.

Authors:  R Javier; K Raska; G J Macdonald; T Shenk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Rapid construction of adenoviral vectors by lambda phage genetics.

Authors:  Duncan McVey; Mohammed Zuber; Damodar Ettyreddy; Douglas E Brough; Imre Kovesdi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  A 72-bp internal deletion in the left inverted terminal repeat of the bovine adenovirus type 3 genome does not affect virus replication.

Authors:  Alberto L van Olphen; Suresh K Mittal
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

6.  Template requirements for in vivo replication of adenovirus DNA.

Authors:  J A Bernstein; J M Porter; M D Challberg
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

7.  McrA and McrB restriction phenotypes of some E. coli strains and implications for gene cloning.

Authors:  E A Raleigh; N E Murray; H Revel; R M Blumenthal; D Westaway; A D Reith; P W Rigby; J Elhai; D Hanahan
Journal:  Nucleic Acids Res       Date:  1988-02-25       Impact factor: 16.971

8.  Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.

Authors:  M I Gorziglia; C Lapcevich; S Roy; Q Kang; M Kadan; V Wu; P Pechan; M Kaleko
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

Authors:  C Chartier; E Degryse; M Gantzer; A Dieterle; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

10.  Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.

Authors:  W W Ye; B B Mason; M Chengalvala; S M Cheng; G Zandle; M D Lubeck; S G Lee; S Mizutani; A R Davis; P P Hung
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.